Timing of Phase III for PancJust for clarification. End of Phase II meeting will require a Type C meeting request, this will take 90 days. The end of Phase II meeting will inform what must be included in the Phase III design.
ONCY will need time to author their IND, which FDA could assess within 30 days.
So realistically, the earliest a Phase III or even Phase II/III for Panc could possibly start will be mid Q2 2023.
That may be of value to some here, and could certainly be an inflection point.